Tetsuya Toge

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Living Beings

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Okita Riki; Yamaguchi Yoshiyuki; Emi Akiko; Matsuura Kazuo; Toge Tetsuya
Enhancement of lymphokine-activated killer cell induction using anti-CD25 and anti-CTLA-4 monoclonal antibodies.
Ohshita Akiko; Yamaguchi Yoshiyuki; Minami Kazuhito; Okita Riki; Toge Tetsuya
Generation of tumor-reactive effector lymphocytes using tumor RNA-introduced dendritic cells in gastric cancer patients.
Matsuura Kazuo; Yamaguchi Yoshiyuki; Ueno Hideaki; Osaki Akihiko; Arihiro Koji; Toge Tetsuya
Maturation of dendritic cells and T-cell responses in sentinel lymph nodes from patients with breast carcinoma.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Tetsuya Toge (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2007: Okita Riki; Yamaguchi Yoshiyuki; Emi Akiko; Matsuura Kazuo; Toge Tetsuya
Enhancement of lymphokine-activated killer cell induction using anti-CD25 and anti-CTLA-4 monoclonal antibodies.
Oncology reports 2007;17(6):1429-35.
2006: Ohshita Akiko; Yamaguchi Yoshiyuki; Minami Kazuhito; Okita Riki; Toge Tetsuya
Generation of tumor-reactive effector lymphocytes using tumor RNA-introduced dendritic cells in gastric cancer patients.
International journal of oncology 2006;28(5):1163-71.
2006: Matsuura Kazuo; Yamaguchi Yoshiyuki; Ueno Hideaki; Osaki Akihiko; Arihiro Koji; Toge Tetsuya
Maturation of dendritic cells and T-cell responses in sentinel lymph nodes from patients with breast carcinoma.
Cancer 2006;106(6):1227-36.
2005: Okita Riki; Hihara Jun; Konishi Kazuo; Osaki Akihiko; Yoshida Kazuhiro; Yamaguchi Yoshiyuki; Toge Tetsuya; Fujimura Kingo; Iwata Takashi; Sawamura Akihiro
Intractable gastrointestinal bleeding from angiodysplasia in a patient of Bernard-Soulier syndrome--report of a case--.
Hiroshima journal of medical sciences 2005;54(4):113-5.
2005: Okita Riki; Saeki Toshiaki; Takashima Shigemitsu; Yamaguchi Yoshiyuki; Toge Tetsuya
CD4+CD25+ regulatory T cells in the peripheral blood of patients with breast cancer and non-small cell lung cancer.
Oncology reports 2005;14(5):1269-73.
2005: Yamaguchi Yoshiyuki; Minami Kazuhito; Kawabuchi Yoshiharu; Emi Manabu; Toge Tetsuya
Anterior resection of rectal cancer through a one hand-size incision with or without laparoscopy: proposal of one hand-size incision surgery (OHaSIS).
The Journal of surgical research 2005;129(1):136-41.
2005: Shimizu Katsuhiko; Hihara Jun; Yoshida Kazuhiro; Toge Tetsuya
Clinical evaluation of low-dose cisplatin and 5-fluorouracil as adjuvant chemoradiotherapy for advanced squamous cell carcinoma of the esophagus.
Hiroshima journal of medical sciences 2005;54(3):67-71.
2005: Mizuiri Hirozumi; Yoshida Kazuhiro; Toge Tetsuya; Oue Naohide; Aung Phyu Phyu; Noguchi Tsuyoshi; Yasui Wataru
DNA methylation of genes linked to retinoid signaling in squamous cell carcinoma of the esophagus: DNA methylation of CRBP1 and TIG1 is associated with tumor stage.
Cancer science 2005;96(9):571-7.
2005: Kim Ryungsa; Osaki Akihiko; Toge Tetsuya
Current and future roles of neoadjuvant chemotherapy in operable breast cancer.
Clinical breast cancer 2005;6(3):223-32; discussion 233-4.
2005: Tanabe Kazuaki; Yoshida Kazuhiro; Hamai Yoichi; Ukon Kei; Ohta Koji; Hihara Jun; Toge Tetsuya
[Clinical study of TS-1 for inoperative and recurrent gastric cancer and evaluation of long survival cases]
Gan to kagaku ryoho. Cancer & chemotherapy 2005;32(8):1145-8.
2005: Ohta Koji; Yoshida Kazuhiro; Tanabe Kazuaki; Hihara Jun; Yamaguchi Yoshiyuki; Toge Tetsuya
[A case report of bowel obstruction due to peritonitis carcinomatosa using combined administration with CPT-11 and CDDP]
Gan to kagaku ryoho. Cancer & chemotherapy 2005;32(7):1063-7.
2005: Tanabe Kazuaki; Yoshida Kazuhiro; Hamai Yoichi; Ukon Kei; Hihara Jun; Toge Tetsuya
[A case of remnant gastric cancer with multiple bone metastasis and peritoneal dissemination; efficacy of combination therapy of docetaxel and TS-1]
Gan to kagaku ryoho. Cancer & chemotherapy 2005;32(7):1037-40.
2005: Tominaga Takeshi; Nomura Yasuo; Horikoshi Noboru; Takashima Shigemitsu; Kimura Morihiko; Koyama Hiroki; Kikkawa Nobuteru; Toge Tetsuya; Mitsuyama Shoshu; Morimoto Tadaoki; Enomoto Koji; Wada Tomio; Kimishima Izo; Niitani Hisanobu;
[Late phase II clinical study of KW-2307 in advanced/recurrent breast cancer patients (II)]
Gan to kagaku ryoho. Cancer & chemotherapy 2005;32(7):983-90.
2005: Yamaguchi Yoshiyuki; Ohta Koji; Kawabuchi Yoshiharu; Ohshita Akiko; Okita Riki; Okawaki Makoto; Hironaka Katsuji; Matsuura Kazuo; Toge Tetsuya
Feasibility study of adoptive immunotherapy for metastatic lung tumors using peptide-pulsed dendritic cell-activated killer (PDAK) cells.
Anticancer research 2005;25(3c):2407-15.
2005: Kim Ryungsa; Tanabe Kazuaki; Emi Manabu; Uchida Yoko; Toge Tetsuya
Modulation of tamoxifen sensitivity by antisense Bcl-2 and trastuzumab in breast carcinoma cells.
Cancer 2005;103(10):2199-207.
2005: Kim Ryungsa; Emi Manabu; Arihiro Koji; Tanabe Kazuaki; Uchida Yoko; Toge Tetsuya
Chemosensitization by STI571 targeting the platelet-derived growth factor/platelet-derived growth factor receptor-signaling pathway in the tumor progression and angiogenesis of gastric carcinoma.
Cancer 2005;103(9):1800-9.
2005: Suzuki Takahisa; Yoshida Kazuhiro; Tanabe Kazuaki; Hihara Jun; Ohta Koji; Hamai Youichi; Taomoto Junya; Toge Tetsuya
[Three advanced gastric cancer patients successfully treated by combination therapy of docetaxel and TS-1]
Gan to kagaku ryoho. Cancer & chemotherapy 2005;32(4):509-13.
2005: Kim Ryungsa; Tanabe Kazuaki; Emi Manabu; Uchida Yoko; Osaki Akihiko; Toge Tetsuya
Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
International journal of oncology 2005;26(4):1025-31.
2005: Yamaguchi Yoshiyuki; Hironaka Katsuji; Okawaki Makoto; Okita Riki; Matsuura Kazuo; Ohshita Akiko; Toge Tetsuya
HER2-specific cytotoxic activity of lymphokine-activated killer cells in the presence of trastuzumab.
Anticancer research 2005;25(2A):827-32.
2005: Ueno Hideaki; Hihara Jun; Shimizu Katsuhiko; Osaki Akihiko; Yamashita Yoshinori; Yoshida Kazuhiro; Toge Tetsuya
Experimental study on fluorescent microspheres as a tracer for sentinel node detection.
Anticancer research 2005;25(2A):821-5.
2005: Saeki Toshiaki; Takashima Shigemitsu; Terashima Masanori; Satoh Atsushi; Toi Masakazu; Osaki Akihiko; Toge Tetsuya; Ohno Shinji; Nomura Naohiro; Fukuyama Yoshio; Koizumi Wasaburo; Taguchi Tetsuo
A Japanese phase I study of continuous oral capecitabine in patients with malignant solid tumors.
International journal of clinical oncology / Japan Society of Clinical Oncology 2005;10(1):51-7.
2005: Ukon Kei; Tanimoto Keiji; Shimokuni Tatsushi; Noguchi Takuya; Hiyama Keiko; Tsujimoto Hiroaki; Fukushima Masakazu; Toge Tetsuya; Nishiyama Masahiko
Activator protein accelerates dihydropyrimidine dehydrogenase gene transcription in cancer cells.
Cancer research 2005;65(3):1055-62.
2005: Noma Kosuke; Yamaguchi Yoshiyuki; Okita Riki; Matsuura Kazuo; Toge Tetsuya
The spleen plays an immunosuppressive role in patients with gastric cancer: involvement of CD62L+ cells and TGF-beta.
Anticancer research 2005;25(1B):643-9.
2005: Minami Kazuhito; Yamaguchi Yoshiyuki; Ohshita Akiko; Kawabuchi Yoshiharu; Ohta Koji; Hihara Jun; Toge Tetsuya
Generation of antigen-presenting cells using cultured dendritic cells and amplified autologous tumor mRNA.
Oncology 2005;69(5):399-407.
2005: Emi Manabu; Kim Ryungsa; Tanabe Kazuaki; Uchida Yoko; Toge Tetsuya
Targeted therapy against Bcl-2-related proteins in breast cancer cells.
Breast cancer research : BCR 2005;7(6):R940-52.
2005: Kimura Shigeru; Kitadai Yasuhiko; Kuwai Toshio; Tanaka Shinji; Hihara Jun; Yoshida Kazuhiro; Toge Tetsuya; Chayama Kazuaki
Expression of p53 protein in esophageal squamous cell carcinoma: relation to hypoxia-inducible factor-1alpha, angiogenesis and apoptosis.
Pathobiology : journal of immunopathology, molecular and cellular biology 2005;72(4):179-85.
2005: Hamai Yoichi; Matsumura Shunji; Matsusaki Keisuke; Kitadai Yasuhiko; Yoshida Kazuhiro; Yamaguchi Yoshiyuki; Imai Kazue; Nakachi Kei; Toge Tetsuya; Yasui Wataru
A single nucleotide polymorphism in the 5' untranslated region of the EGF gene is associated with occurrence and malignant progression of gastric cancer.
Pathobiology : journal of immunopathology, molecular and cellular biology 2005;72(3):133-8.
2004: Kim Ryungsa; Emi Manabu; Tanabe Kazuaki; Toge Tetsuya
Therapeutic potential of antisense Bcl-2 as a chemosensitizer for cancer therapy.
Cancer 2004;101(11):2491-502.
2004: Yoshida Kazuhiro; Toge Tetsuya
[Combination chemotherapy of TS-1 and docetaxel on advanced and recurrent gastric cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 2004;31(12):1982-6.
2004: Takahashi Yutaka; Takeuchi Tetsuo; Sakamoto Jyunichi; Mai Masayoshi; Kitajima Masaki; Kubota Tetsuro; Toge Tetsuya; Saji Shigetoyo
[A randomized phase II clinical trial of tailored CPT-11 + TS-1 vs TS-1 in patients with advanced or recurrent gastric carcinoma as the first-line chemotherapy (JFMC31-0301)]
Gan to kagaku ryoho. Cancer & chemotherapy 2004;31(12):1969-72.
2004: Kim Ryungsa; Emi Manabu; Tanabe Kazuaki; Toge Tetsuya
Preclinical evaluation of antisense bcl-2 as a chemosensitizer for patients with gastric carcinoma.
Cancer 2004;101(10):2177-86.
2004: Kim Ryungsa; Toge Tetsuya
Multidisciplinary approach to cancer treatment: a model for breast cancer treatment at the M.D. Anderson Cancer Center.
International journal of clinical oncology / Japan Society of Clinical Oncology 2004;9(5):356-63.
2004: Kim Ryungsa; Inoue Hideki; Toge Tetsuya
Bax is an important determinant for radiation sensitivity in esophageal carcinoma cells.
International journal of molecular medicine 2004;14(4):697-706.
2004: Tanaka Tomotaka; Tanimoto Keiji; Otani Keiko; Satoh Kenichi; Ohtaki Megu; Yoshida Kazuhiro; Toge Tetsuya; Yahata Hiroshi; Tanaka Shinji; Chayama Kazuaki; Okazaki Yasushi; Hayashizaki Yoshihide; Hiyama Keiko; Nishiyama Masahiko
Concise prediction models of anticancer efficacy of 8 drugs using expression data from 12 selected genes.
International journal of cancer. Journal international du cancer 2004;111(4):617-26.
2004: Kimura Shigeru; Kitadai Yasuhiko; Tanaka Shinji; Kuwai Toshio; Hihara Jun; Yoshida Kazuhiro; Toge Tetsuya; Chayama Kazuaki
Expression of hypoxia-inducible factor (HIF)-1alpha is associated with vascular endothelial growth factor expression and tumour angiogenesis in human oesophageal squamous cell carcinoma.
European journal of cancer (Oxford, England : 1990) 2004;40(12):1904-12.
2004: Yoshida Kazuhiro; Toge Tetsuya
[Telomerase activity in gastrointestinal, bladder and breast carcinomas and their clinical applications]
Nippon rinsho. Japanese journal of clinical medicine 2004;62(7):1368-76.
2004: Yanagihara Kazuyoshi; Tanaka Hiromi; Takigahira Misato; Ino Yoshinori; Yamaguchi Yoshiyuki; Toge Tetsuya; Sugano Kokichi; Hirohashi Setsuo
Establishment of two cell lines from human gastric scirrhous carcinoma that possess the potential to metastasize spontaneously in nude mice.
Cancer science 2004;95(7):575-82.
2004: Takahashi Yutaka; Sakamoto Junichi; Takeuchi Tetsuo; Mai Masayoshi; Kubota Tetsuro; Kitajima Masaki; Tanigawara Yusuke; Komatsu Yoshito; Toge Tetsuya; Saji Shigetoyo
A randomized phase II clinical trial of tailored CPT-11 + S-1 vs S-1 in patients with advanced or recurrent gastric carcinoma as the first line chemotherapy.
Japanese journal of clinical oncology 2004;34(6):342-5.
2004: Kim Ryungsa; Emi Manabu; Tanabe Kazuaki; Uchida Yoko; Toge Tetsuya
The role of Fas ligand and transforming growth factor beta in tumor progression: molecular mechanisms of immune privilege via Fas-mediated apoptosis and potential targets for cancer therapy.
Cancer 2004;100(11):2281-91.
2004: Kim Ryungsa; Osaki Akihiko; Tanabe Kazuaki; Toge Tetsuya
Neoadjuvant chemotherapy for local advanced breast cancer with stage IIIB.
Oncology reports 2004;11(6):1265-72.
2004: Yoshida Kazuhiro; Hirabayashi Naoki; Takiyama Wataru; Ninomiya Motoki; Takakura Norihisa; Sakamoto Jyunnichi; Nishiyama Masahiko; Toge Tetsuya
Phase I study of combination therapy with S-1 and docetaxel (TXT) for advanced or recurrent gastric cancer.
Anticancer research 2004;24(3b):1843-51.
2004: Fujii Daisuke; Yoshida Kazuhiro; Tanabe Kazuaki; Hihara Jun; Toge Tetsuya
The ligands of peroxisome proliferator-activated receptor (PPAR) gamma inhibit growth of human esophageal carcinoma cells through induction of apoptosis and cell cycle arrest.
Anticancer research 2004;24(3a):1409-16.
2004: Matsumura Shunji; Oue Naohide; Kitadai Yasuhiko; Chayama Kazuaki; Yoshida Kazuhiro; Yamaguchi Yoshiyuki; Toge Tetsuya; Imai Kazue; Nakachi Kei; Yasui Wataru
A single nucleotide polymorphism in the MMP-1 promoter is correlated with histological differentiation of gastric cancer.
Journal of cancer research and clinical oncology 2004;130(5):259-65.
2004: Yamaguchi Yoshiyuki; Ohshita Akiko; Kawabuchi Yoshiharu; Hihara Jun; Miyahara Eiji; Noma Kosuke; Toge Tetsuya
Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment.
International journal of oncology 2004;24(4):959-66.
2004: Yamaguchi Yoshiyuki; Minami Kazuhito; Ohshita Akiko; Kawabuchi Yoshiharu; Noma Kosuke; Toge Tetsuya
Enhancing effect of PS-K on IL-2-induced lymphocyte activation: possible involvement of antagonistic action against TGF-beta.
Anticancer research 2004;24(2B):639-47.
2004: Kawabuchi Yoshiharu; Yamaguchi Yoshiyuki; Ohshita Akiko; Minami Kazuhito; Toge Tetsuya
Host-oriented peptide evaluation using whole blood assay for generating antigen-specific cytotoxic T lymphocytes.
Anticancer research 2004;24(2C):1193-200.
2004: Kim Ryungsa; Tanabe Kazuaki; Emi Manabu; Uchida Yoko; Toge Tetsuya
Potential roles of antisense therapy in the molecular targeting of genes involved in cancer (review).
International journal of oncology 2004;24(1):5-17.
2004: Kim Ryungsa; Toge Tetsuya
Changes in therapy for solid tumors: potential for overcoming drug resistance in vivo with molecular targeting agents.
Surgery today 2004;34(4):293-303.
2003: Yamaguchi Yoshiyuki; Ohshita Akiko; Kawabuchi Yoshiharu; Ohta Koji; Shimizu Katsuhiko; Minami Kazuhito; Hihara Jun; Miyahara Eiji; Toge Tetsuya
Adoptive immunotherapy of cancer using activated autologous lymphocytes--current status and new strategies.
Human cell : official journal of Human Cell Research Society 2003;16(4):183-9.
2003: Yoshida Kazuhiro; Ohta Koji; Hihara Jun; Tanabe Kazuaki; Minami Kazuhito; Yamaguchi Yoshiyuki; Toge Tetsuya
[Weekly docetaxel therapy is useful for gastric carcinoma as a second-line chemotherapy]
Gan to kagaku ryoho. Cancer & chemotherapy 2003;30(12):1927-32.
2003: Hihara Jun; Ueno Hideaki; Toge Tetsuya
[A new tracer for sentinel node detection in esophageal and lung cancer--fluorescent microspheres]
Nippon Geka Gakkai zasshi 2003;104(11):762-4.
2003: Toge Tetsuya
[Sentinel node navigation surgery: a present status and the future directions]
Nippon Geka Gakkai zasshi 2003;104(11):745-6.
2003: Yamaguchi Y; Miyahara E; Ohshita A; Kawabuchi Y; Ohta K; Shimizu K; Minami K; Hihara J; Sawamura A; Toge T
Locoregional immunotherapy of malignant effusion from colorectal cancer using the streptococcal preparation OK-432 plus interleukin-2: induction of autologous tumor-reactive CD4+ Th1 killer lymphocytes.
British journal of cancer 2003;89(10):1876-84.
2003: Kim Ryungsa; Tanabe Kazuaki; Emi Manabu; Uchida Yoko; Toge Tetsuya
Death receptor-dependent and -independent pathways in anticancer drug-induced apoptosis of breast cancer cells.
Oncology reports 2003;10(6):1925-30.
2003: Minami Kazuhito; Yamaguchi Yoshiyuki; Ohshita Akiko; Kawabuchi Yoshiharu; Shimizu Katsuhiko; Ohta Kouji; Hihara Jun; Miyahara Eiji; Toge Tetsuya
[Tumor RNA introduction into dendritic cells and Epstein-Barr virus transformed B cells]
Gan to kagaku ryoho. Cancer & chemotherapy 2003;30(11):1813-6.
2003: Ohshita Akiko; Yamaguchi Yoshiyuki; Minami Kazuhito; Miyahara Eiji; Kawabuchi Yoshiharu; Shimizu Katsuhiko; Ohta Koji; Hihara Jun; Toge Tetsuya
[Generation of TRiDAK (tumor RNA-introduced dendritic cell-activated killer) cells]
Gan to kagaku ryoho. Cancer & chemotherapy 2003;30(11):1809-12.
2003: Kim Ryungsa; Emi Manabu; Tanabe Kazuaki; Uchida Yoko; Toge Tetsuya
Chemosensitivity testing for gastrointestinal cancer: survival benefit potential and limitations.
Anti-cancer drugs 2003;14(9):715-23.
2003: Yamaguchi Yoshiyuki; Minami Kazuhito; Toge Tetsuya
[Informed consent in the treatment of colorectal cancer]
Nippon rinsho. Japanese journal of clinical medicine 2003;61 Suppl 7():564-8.
2003: Kim Ryungsa; Osaki Akihiko; Kaneko Mayumi; Inai Kouki; Toge Tetsuya
Factors that influence the incidence of microscopic carcinoma in frozen and preserved specimens from patients with breast carcinoma after breast-conserving surgery.
Oncology reports 2003;10(5):1321-8.
2003: Hamai Yoichi; Oue Naohide; Mitani Yoshitsugu; Nakayama Hirofumi; Ito Reiko; Matsusaki Keisuke; Yoshida Kazuhiro; Toge Tetsuya; Yasui Wataru
DNA hypermethylation and histone hypoacetylation of the HLTF gene are associated with reduced expression in gastric carcinoma.
Cancer science 2003;94(8):692-8.
2003: Kim Ryungsa; Tanabe Kazuaki; Uchida Yoko; Emi Manabu; Toge Tetsuya
Effect of Bcl-2 antisense oligonucleotide on drug-sensitivity in association with apoptosis in undifferentiated thyroid carcinoma.
International journal of molecular medicine 2003;11(6):799-804.
2003: Tanabe Kazuaki; Kim Ryungsa; Inoue Hideki; Emi Manabu; Uchida Yoko; Toge Tetsuya
Antisense Bcl-2 and HER-2 oligonucleotide treatment of breast cancer cells enhances their sensitivity to anticancer drugs.
International journal of oncology 2003;22(4):875-81.
2003: Kim Ryungsa; Murakami Shigeru; Toge Tetsuya
Effects of introduction of dThdPase cDNA on sensitivity to 5'-deoxy-5-fluorouridine and tumor angiogenesis.
International journal of oncology 2003;22(4):835-41.
2003: Kim Ryungsa; Toge Tetsuya
Clinical relevance of meta-analysis of survival benefit when deciding treatment of adjuvant chemotherapy in gastric cancer.
Anticancer research 2003;23(2C):1843-6.
2003: Ueno Hideaki; Yoshida Kazuhiro; Hirai Toshihiro; Kono Fujiko; Kambe Masayuki; Toge Tetsuya
Quantitative detection of carcinoembryonic antigen messenger RNA in the peritoneal cavity of gastric cancer patients by real-time quantitative reverse transcription polymerase chain reaction.
Anticancer research 2003;23(2C):1701-8.
2003: Yamashita Yoshinori; Miyahara Eiji; Shimizu Katsuhiko; Toge Tetsuya; Adrian Thomas E
Screening of gastrointestinal hormone release in patients with lung cancer.
In vivo (Athens, Greece) 2003;17(2):193-5.
2003: Tominaga Takeshi; Koyama Hiroki; Toge Tetsuya; Miura Shigeto; Sugimachi Keizo; Yamaguchi Susumu; Hirata Koichi; Monden Yasumasa; Nomura Yasuo; Toi Masakazu; Kimijima Izo; Noguchi Shinzaburo; Sonoo Hiroshi; Asaishi Kazuaki; Ikeda Tadashi; Morimoto Tadaoki; Ota Jun; Ohashi Yasuo; Abe Osahiko
Randomized controlled trial comparing oral doxifluridine plus oral cyclophosphamide with doxifluridine alone in women with node-positive breast cancer after primary surgery.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(6):991-8.
2003: Yoshida Kazuhiro; Tanabe Kazuaki; Fujii Daisuke; Oue Naohide; Yasui Wataru; Toge Tetsuya
Induction mechanism of apoptosis by troglitazone through peroxisome proliferator-activated receptor-gamma in gastric carcinoma cells.
Anticancer research 2003;23(1A):267-73.
2003: Kim Ryungsa; Tanabe Kazuaki; Emi Manabu; Uchida Yoko; Inoue Hideki; Toge Tetsuya
Inducing cancer cell death by targeting transcription factors.
Anti-cancer drugs 2003;14(1):3-11.
2003: Kim Ryungsa; Osaki Akihiko; Toge Tetsuya
Feasibility and therapeutic efficacy of weekly 1-h low-dose paclitaxel infusion for relapsed breast cancer.
Oncology reports 2003;10(1):145-50.
2003: Yoshida Kazuhiro; Tanabe Kazuaki; Ueno Hideaki; Ohta Kouji; Hihara Jun; Toge Tetsuya; Nishiyama Masahiko
Future prospects of personalized chemotherapy in gastric cancer patients: results of a prospective randomized pilot study.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2003;6 Suppl 1():82-9.
2002: Saji Shigetoyo; Toge Tetsuya; Kurosu Yasuhiko; Hirata Koichi; Gochi Akira; Tominaga Suketami; Inokuchi Kiyoshi
[Interim report of JFMC study no. 23--phase III randomized clinical trial on the effectiveness of low-dose cisplatin plus 5-FU as a postoperative adjuvant chemotherapy for advanced gastric cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 2002;29(13):2499-507.
2002: Yano Yasuo; Yoshida Kazuhiro; Osaki Akihiko; Toge Tetsuya; Tahara Hidetoshi; Ide Toshinori; Yasui Wataru
Expression and distribution of human telomerase catalytic component, hTERT, in human breast tissues.
Anticancer research 2002;22(6C):4101-7.
2002: Kim Ryungsa; Tanabe Kazuaki; Uchida Yoko; Emi Manabu; Inoue Hideki; Toge Tetsuya
Current status of the molecular mechanisms of anticancer drug-induced apoptosis. The contribution of molecular-level analysis to cancer chemotherapy.
Cancer chemotherapy and pharmacology 2002;50(5):343-52.
2002: Ohta Koji; Yamaguchi Yoshiyuki; Shimizu Katsuhiko; Miyahara Eiji; Toge Tetsuya
Novel system for generating cytotoxic effector lymphocytes using carcinoembryonic antigen (CEA) peptide and cultured dendritic cells.
Anticancer research 2002;22(5):2597-606.
2002: Shimizu Katsuhiko; Yamashita Yoshinori; Hihara Jun; Seto Yoshihiro; Toge Tetsuya
Cavernous hemangioma of the rib.
The Annals of thoracic surgery 2002;74(3):932-4.
2002: Kim Ryungsa; Yamaguchi Yoshiyuki; Toge Tetsuya
Adjuvant therapy for colorectal carcinoma.
Anticancer research 2002;22(4):2413-8.
2002: Toge Tetsuya; Kin Takashi; Yoshida Kazuhiro; Hirata Koichi
[Postoperative adjuvant therapy of gastric and colonic cancers]
Gan to kagaku ryoho. Cancer & chemotherapy 2002;29(6):1015-24.
2002: Toge Tetsuya
[Molecular diagnosis of cancer--the progress of its applications for diagnosis and treatment of cancer]
Nippon Geka Gakkai zasshi 2002;103(6):455-6.
2002: Shimizu Katsuhiko; Yamaguchi Yoshiyuki; Ohta Koji; Miyahara Eiji; Toge Tetsuya
Analysis of T cell receptors reactive with squamous cell carcinoma antigen SART-1 presented by the HLA-A24 molecule.
Oncology reports 2002;9(3):599-605.
2002: Tohdo Hiroko; Akagi Morihisa; Chikamatsu Sonoko; Miura Toshio; Watanabe Tetsuhiko; Haruma Ken; Shimamoto Fumio; Yoshida Kazuhiro; Toge Tetsuya
[A case of multiple gastric carcinoid tumor with type A gastritis treated by distal gastrectomy]
Nippon Shokakibyo Gakkai zasshi The Japanese journal of gastro-enterology 2002;99(4):386-90.
2002: Kim Ryungsa; Tanabe Kazuaki; Inoue Hideki; Toge Tetsuya
Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
International journal of oncology 2002;20(3):549-55.
2002: Tominaga Takeshi; Toi Masakazu; Abe Osahiko; Ohashi Yasuo; Uchino Junichi; Hayasaka Hiroshi; Abe Rikiya; Izuo Masaru; Enomoto Kohji; Watanabe Hiromu; Yoshida Minoru; Taguchi Tetsuo; Koyama Hiroki; Senoo Tsuneaki; Toge Tetsuya; Monden Yasumasa; Hattori Takao; Nomura Yasuo; Sugimachi Keizo; Hirata Koichi; Nakazato Hiroaki; Miura Shigeto; Morimoto Tadaoki; Asaishi Kazuaki; Kimijima Izo; Ota Jun; Sonoo Hiroshi; Yamaguchi Susumu;
The effect of adjuvant 5'-deoxy-5-fluorouridine in early stage breast cancer patients: results from a multicenter randomized controlled trial.
International journal of oncology 2002;20(3):517-25.
2002: Kim Ryungsa; Yoshida Kazuhiro; Toge Tetsuya
Current status and future perspectives of post-operative adjuvant therapy for gastric carcinoma.
Anticancer research 2002;22(1A):283-9.
2002: Kim Ryungsa; Tanabe Kazuaki; Uchida Yoko; Osaki Akihiko; Toge Tetsuya
The role of HER-2 oncoprotein in drug-sensitivity in breast cancer (review).
Oncology reports 2002;9(1):3-9.
2002: Kim Ryungsa; Osaki Akihiko; Hirai Toshihiro; Toge Tetsuya
Utility of technetium-99m methoxyisobutyl isonitrile uptake analysis for prediction of the response to chemotherapy in advanced and relapsed breast cancer.
Breast cancer (Tokyo, Japan) 2002;9(3):240-7.
2001: Kim R; Osaki A; Toge T
A pitfall in the survival benefit of adjuvant chemotherapy for node- and hormone receptor-positive patients with breast cancer: the paradoxical role of Bcl-2 oncoprotein (review).
International journal of oncology 2001;19(5):1075-80.
2001: Kim R; Osaki A; Kojima J; Toge T
Significance of lymphoscintigraphic mapping with Tc-99m human serum albumin and tin colloid in sentinel lymph node biopsy in breast cancer.
International journal of oncology 2001;19(5):991-6.
2001: Yoshida K; Nishimoto N; Kagawa Y; Hihara J; Inoue H; Kim R; Hirai T; Nishiyama M; Toge T
[A new therapeutic approach to advanced and recurrent gastric cancer by TS-1]
Gan to kagaku ryoho. Cancer & chemotherapy 2001;28(10):1403-12.
2001: Kim R; Yoshida K; Toge T
[Current status and future perspectives on chemotherapy in patients with gastric cancer: can the clinical data from Japan lead to a standard international therapy?]
Nippon Geka Gakkai zasshi 2001;102(10):770-7.
2001: Kim R; Osaki A; Toge T
Pharmacokinetic and biochemical analysis in the treatment of weekly paclitaxel in relapsed breast cancer.
Oncology reports 2001;8(5):1171-6.
2001: Hirai T; Toge T
[Treatment of lymph node metastasis from the viewpoint of surgical oncology]
Nippon Geka Gakkai zasshi 2001;102(6):453-8.
2001: Kim R; Inoue H; Tanabe K; Toge T
Effect of inhibitors of cysteine and serine proteases in anticancer drug-induced apoptosis in gastric cancer cells.
International journal of oncology 2001;18(6):1227-32.
2001: Minami K; Yamaguchi Y; Yoshida K; Quan C P; Toge T
Dysregulation of telomerase activity and expression in lymphokine-activated killer cells from advanced cancer patients: possible involvement in cancer-associated immunosuppression mechanism.
Oncology reports 2001;8(3):649-53.
2001: Kim R; Osaki A; Tanabe K; Kojima J; Toge T
A phase II trial of mitomycin C, 5'-deoxy-5-fluorouridine, etoposide and medroxyprogesterone acetate (McVD-MPA) as a salvage chemotherapy to anthracycline-resistant tumor in relapsed breast cancer and its mechanism(s) of antitumor action.
Oncology reports 2001;8(3):597-603.
2001: Yoshida K; Toge T; Kuniyasu H; Yasui W; Tahara E
[Molecular mechanisms of carcinogenesis in human stomach cancer: K-sam gene]
Nippon rinsho. Japanese journal of clinical medicine 2001;59 Suppl 4():53-9.
2001: Yoshida K; Toge T
[Adjuvant chemotherapy for gastric cancer]
Nippon rinsho. Japanese journal of clinical medicine 2001;59 Suppl 4():449-55.
2001: Ohta K; Sawamura A; Miyahara E; Kim R; Toge T
[A case of inoperable advanced gall bladder cancer responding to intra-arterial infusion of 5-fluorouracil (5-FU) and leucovorin (LV)]
Gan to kagaku ryoho. Cancer & chemotherapy 2001;28(4):516-9.
2001: Kim R; Minami K; Nishimoto N; Toge T
Enhancement of antitumor effect by intratumoral administration of bax gene in combination with anticancer drugs in gastric cancer.
International journal of oncology 2001;18(2):363-7.
2001: Yamaguchi Y; Ohta K; Shimizu K; Minami K; Noma K; Hihara J; Toge T
Generation of cytotoxic effector lymphocytes by MLTC using tumor cells genetically modified to secrete interleukin-2.
Anticancer research 2001;21(1B):669-77.
2001: Kim R; Nishimoto N; Osaki A; Kojima J; Fujii S; Inai K; Toge T
An analysis of relapsed breast cancer in patients previously treated with breast conserving surgery.
Breast cancer (Tokyo, Japan) 2001;8(2):146-52.
2000: Yamaguchi Y; Sawamura A; Minami K; Miyahara E; Toge T
[Locoregional immunotherapy of malignant effusions for colorectal cancer using OK-432 and its acting mechanisms--possibility of molecular diagnosis using TCRCDR 3 sequence]
Gan to kagaku ryoho. Cancer & chemotherapy 2000;27(12):1870-3.
2000: Tominaga T; Kimura M; Toge T; Takashima S; Nomura Y; Ohashi Y
[A combined effect of fadrozole and tamoxifen in postmenopausal patients with recurrent breast cancer: a preliminary report: Japanese Cooperative Study Group of Fadrozole and Tamoxifen]
Gan to kagaku ryoho. Cancer & chemotherapy 2000;27(11):1709-18.
2000: Toge T; Yamaguchi Y
Protein-bound polysaccharide increases survival in resected gastric cancer cases stratified with a preoperative granulocyte and lymphocyte count.
Oncology reports 2000;7(5):1157-61.
2000: Yamaguchi Y; Takashima I; Hihara J; Ohta K; Shimizu K; Minami K; Yoshida K; Toge T
Co-transduction of herpes simplex virus thymidine kinase gene and human interleukin-2 gene into mouse ovarian cancer cell line, OVHM.
International journal of molecular medicine 2000;6(2):185-90.
2000: Murakami S; Yoshida K; Kin R; Nishimoto N; Kagawa Y; Yano Y; Nishiyama M; Hirai T; Toge T
[The clinical effect of low-dose FP (5-FU + low-dose CDDP) in patients with far advanced gastric cancer, and their quality of life]
Gan to kagaku ryoho. Cancer & chemotherapy 2000;27(6):853-8.
2000: Ohi Y; Kim R; Toge T
Overcoming of multidrug resistance by introducing the apoptosis gene, bcl-Xs, into MRP-overexpressing drug resistant cells.
International journal of oncology 2000;16(5):959-69.
2000: Yamashita Y; Inoue H; Ohta K; Yoshida K; Miyahara E; Hirai T; Toge T; Adrian T E
Manometric and hormonal changes after distal partial gastrectomy.
Alimentary pharmacology & therapeutics 2000;14 Suppl 1():166-9.
2000: Toge T; Nakazato H; Nishiyama M; Hirata K; Yamamitsu S; Sowa M; Saji S
[Current status of "low-dose cisplatin-5-FU therapy" for solid tumors (2nd report)--from a nationwide questionnaire on its adverse effects]
Gan to kagaku ryoho. Cancer & chemotherapy 2000;27(4):549-58.
2000: Toge T; Fujita M; Hirata K; Kunii Y; Kitamura M; Nagawa H; Kubota T; Wakasugi J; Kasai Y; Takahashi Y; Furukawa H; Takao T; Kaibara N; Takashima S; Kakegawa T; Tomita M; Nose Y
[Interim report of JFMTC study no. 20 on the effectiveness of high dose CDDP plus 5-FU regimen as an adjuvant therapy for far-advanced cancer of the stomach]
Gan to kagaku ryoho. Cancer & chemotherapy 2000;27(3):395-403.
2000: Kim R; Ohi Y; Inoue H; Toge T
Enhancement of chemotherapeutic agents induced-apoptosis associated with activation of c-Jun N-terminal kinase 1 and caspase 3 (CPP32) in bax-transfected gastric cancer cells.
Anticancer research 2000;20(1A):439-44.
2000: Kagawa Y; Yoshida K; Hirai T; Toge T; Yokozaki H; Yasui W; Tahara E
Microsatellite instability in squamous cell carcinomas and dysplasias of the esophagus.
Anticancer research 2000;20(1A):213-7.
2000: Hirai T; Hihara J; Inoue M; Nishimoto N; Kagawa Y; Yoshida K; Toge T
Significance of lymph node dissection of the superior mediastinal region in esophageal cancer patients.
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus / I.S.D.E 2000;13(3):198-202.
2000: Kagawa Y; Yoshida K; Hirai T; Toge T
Significance of the expression of p27Kip1 in esophageal squamous cell carcinomas.
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus / I.S.D.E 2000;13(3):179-84.
1999: Kim R; Ohi Y; Inoue H; Toge T
Taxotere activates transcription factor AP-1 in association with apoptotic cell death in gastric cancer cell lines.
Anticancer research 1999;19(6B):5399-405.
1999: Kim R; Ohi Y; Inoue H; Toge T
Expression and relationship between topoisomerase I and II alpha genes in tumor and normal tissues in esophageal, gastric and colon cancers.
Anticancer research 1999;19(6B):5393-8.
1999: Takashima I; Yamaguchi Y; Yorishima T; Ohta K; Minami K; Hihara J; Toge T
Immunological properties of tumor cells genetically modified to secrete interleukin-2.
Anticancer research 1999;19(6B):5299-306.
1999: Kim R; Murakami S; Ohi Y; Inoue H; Yoshida K; Toge T
A phase II trial of low dose administration of 5-fluorouracil and cisplatin in patients with advanced and recurrent gastric cancer.
International journal of oncology 1999;15(5):921-6.
1999: Kim R; Ohi Y; Inoue H; Toge T
Activation and the interaction of proapoptotic genes in modulating sensitivity to anticancer drugs in gastric cancer cells.
International journal of oncology 1999;15(4):751-6.
1999: Hirai T; Kuwahara M; Yoshida K; Osaki A; Toge T
The prognostic significance of p53, p21 (Waf1/Cip1), and cyclin D1 protein expression in esophageal cancer patients.
Anticancer research 1999;19(5C):4587-91.
1999: Miyahara E; Yamaguchi Y; Minami K; Hihara J; Noma K; Toge T; Takafuta T; Fujimura K
T-cell receptor V beta gene usage of human cytotoxic T-cell clones obtained from gastric cancer patients.
Anticancer research 1999;19(3A):2057-66.
1999: Kim R; Ohi Y; Inoue H; Aogi K; Toge T
Introduction of gadd153 gene into gastric cancer cells can modulate sensitivity to anticancer agents in association with apoptosis.
Anticancer research 1999;19(3A):1779-83.
1999: Hihara J; Yamaguchi Y; Minami K; Noma K; Toge T
Down-regulation of IL-10 enhances the efficacy of locoregional immunotherapy using OK-432 against malignant effusion.
Anticancer research 1999;19(2A):1077-84.
1999: Kirihara Y; Yamamoto W; Toge T; Nishiyama M
Dihydropyrimidine dehydrogenase, multidrug resistance-associated protein, and thymidylate synthase gene expression levels can predict 5-fluorouracil resistance in human gastrointestinal cancer cells.
International journal of oncology 1999;14(3):551-6.
1999: Hihara J; Hirai T; Yamashita Y; Yoshida K; Kuwahara M; Kagawa Y; Toge T
Poor prognosis in esophageal cancer patients with post-operative complications: surgical oncotaxis.
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus / I.S.D.E 1999;12(2):152-4.
1999: Kuwahara M; Hirai T; Yoshida K; Yamashita Y; Hihara J; Inoue H; Toge T
p53, p21(Waf1/Cip1) and cyclin D1 protein expression and prognosis in esophageal cancer.
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus / I.S.D.E 1999;12(2):116-9.
1999: Yamashita Y; Hirai T; Mukaida H; Yoshimoto A; Kuwahara M; Inoue H; Toge T
Finger bougie method compared with pyloroplasty in the gastric replacement of the esophagus.
Surgery today 1999;29(2):107-10.
1999: Aogi K; Hirai T; Mukaida H; Toge T; Haruma K; Kajiyama G
Laparoscopic resection of submucosal gastric tumors.
Surgery today 1999;29(2):102-6.
1998: Yoshida K; Yasui W; Yokozaki H; Nishimoto N; Kagawa Y; Toge T; Tahara E; Yoshida T; Terada M
[New molecular prognostic markers in gastric carcinoma]
Gan to kagaku ryoho. Cancer & chemotherapy 1998;25(13):2021-7.
1998: Hirai T; Kuwahara M; Yoshida K; Kagawa Y; Hihara J; Yamashita Y; Toge T
Clinical results of transhiatal esophagectomy for carcinoma of the lower thoracic esophagus according to biological markers.
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus / I.S.D.E 1998;11(4):221-5.
1998: Sawamura A; Aogi K; Yoshida K; Miyahara E; Minami K; Toge T
[Usefulness of percutaneous low output microwave tissue coagulation therapy for solitary liver cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 1998;25(9):1366-9.
1998: Mukaida H; Hirai T; Yamashita Y; Yoshida K; Hihara J; Kuwahara M; Inoue H; Toge T
Clinical evaluation of adjuvant chemoradiotherapy with CDDP, 5-FU, and VP-16 for advanced esophageal cancer.
The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi 1998;46(1):11-7.
1998: Hirai T; Yamashita Y; Mukaida H; Kuwahara M; Inoue H; Toge T
Poor prognosis in esophageal cancer patients with postoperative complications.
Surgery today 1998;28(6):576-9.
1997: Saji S; Aiba K; Araki H; Sasaki K; Shirasaka T; Sowa M; Tanaka M; Chung Y; Toge T; Hirata K; Yasumoto K; Yamamitsu S; Wada H
[Current status of low-dose CDDP. 5-FU therapy for solid malignant tumors--nationwide questionnaire survey]
Gan to kagaku ryoho. Cancer & chemotherapy 1997;24(13):1892-900.
1997: Sawamura A; Kim R; Takashima I; Miyahara E; Aogi K; Yamaguchi Y; Noma K; Hihara J; Toge T
[A case of advanced hepatocellular carcinoma with portal invasion effectively treated by continuous intra-arterial chemotherapy with 5-fluorouracil]
Gan to kagaku ryoho. Cancer & chemotherapy 1997;24(12):1738-40.
1997: Sawamura A; Miyahara E; Aogi K; Hihara J; Noma K; Minami K; Yoshida K; Yamaguchi Y; Toge T
[Usefulness of percutaneous microwave tissue coagulation therapy for solitary liver cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 1997;24(12):1643-6.
1997: Nishiyama M; Suzuki K; Kumazaki T; Yamamoto W; Toge T; Okamura T; Kurisu K
Molecular targeting of mitomycin C chemotherapy.
International journal of cancer. Journal international du cancer 1997;72(4):649-56.
1997: Aogi K; Nishiyama M; Kim R; Hirabayashi N; Toge T; Mizutani A; Okada K; Sumiyoshi H; Fujiwara Y; Yamakido M; Kusano T; Andoh T
Overcoming CPT-11 resistance by using a biscoclaurine alkaloid, cepharanthine, to modulate plasma trans-membrane potential.
International journal of cancer. Journal international du cancer 1997;72(2):295-300.
1997: Sakamoto N; Toge T; Nishiyama M
Tumor-specific synergistic therapy of mitomycin C: modulation of bioreductive activation.
Hiroshima journal of medical sciences 1997;46(2):67-73.
1997: Nishiyama M; Toge T
Selection of adjuvant chemotherapy for gastric cancer using objective criteria.
Gan to kagaku ryoho. Cancer & chemotherapy 1997;24 Suppl 1():232-8.
1997: Yamashita Y; Toge T; Adrian T E
Gastrointestinal hormone in dumping syndrome and reflux esophagitis after gastric surgery.
Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi 1997;33(2):37-48.
1997: Hirai T; Yoshimoto A; Iwata T; Yamashita Y; Kuwahara M; Toge T
Enhancing effect of thoraco-laparotomy on liver metastasis and the role played by active oxygens in its mechanism.
Surgery today 1997;27(11):1040-5.
1996: Iwata T; Hirai T; Yamashita Y; Yoshimoto A; Kuwahara M; Toge T
[Repair of the gastric tube-right main bronchus fistula after operation for esophageal cancer--treatment by transposition of pedicled pectoralis major muscle flap]
[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai 1996;44(9):1753-8.
1996: Sawamura A; Aogi K; Yoshimoto A; Yamaguchi Y; Miyahara E; Kawami H; Hihara J; Noma K; Toge T
[Usefulness of subcutaneous implantable port with new one-way valve]
Gan to kagaku ryoho. Cancer & chemotherapy 1996;23(11):1555-7.
1996: Miyahara E; Yamaguchi Y; Hihara J; Noma K; Toge T
Profile of T-cell receptor V beta gene usage of cytotoxic T cells induced by intrapleural administration of a streptococcal preparation, OK432, in malignant effusions.
Journal of experimental therapeutics & oncology 1996;1(4):242-50.
1996: Ando Y; Watanabe H; Tatematsu M; Hirano K; Furihata C; Fujimoto N; Toge T; Ito A
Gastric tumorigenicity of 1,2-dimethylhydrazine on the background of gastric intestinal metaplasia induced by X-irradiation in CD (SD) rats.
Japanese journal of cancer research : Gann 1996;87(5):433-6.
1996: Toge T
[Progress of adjuvant chemotherapy in colon cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 1996;23(5):554-9.
1995: Yamaguchi Y; Takashima I; Toge T
[Treatment of experimental ascites with retroviral vector producer cells inserted with human interleukin-2 gene: preliminary report]
Nippon Geka Gakkai zasshi 1995;96(10):727.
1995: Ando Y; Watanabe H; Fujimoto N; Ito A; Toge T
Progesterone enhancement of stomach tumor development in SD rats treated with N-methyl-N'-nitro-N-nitrosoguanidine.
Japanese journal of cancer research : Gann 1995;86(10):924-8.
1995: Yamaguchi Y; Satoh Y; Miyahara E; Noma K; Funakoshi M; Takashima I; Sawamura A; Toge T
Locoregional immunotherapy of malignant ascites by intraperitoneal administration of OK-432 plus IL-2 in gastric cancer patients.
Anticancer research 1995;15(5B):2201-6.
1995: Saeki S; Nishiyama M; Toge T
DT-diaphorase as a target enzyme for biochemical modulation of mitomycin C.
Hiroshima journal of medical sciences 1995;44(3):55-63.
1995: Miyahara E; Yamaguchi Y; Hihara J; Noma K; Funakoshi M; Takashima I; Sawamura A; Toge T
[T cell receptor V beta repertoire of locoregional lymphocytes in malignant effusions]
Gan to kagaku ryoho. Cancer & chemotherapy 1995;22(11):1622-5.
1995: Yoshida K; Kawami H; Yamaguchi Y; Kuniyasu H; Nishiyama M; Hirai T; Yanagihara K; Tahara E; Toge T
Retrovirally transmitted gene therapy for gastric carcinoma using herpes simplex virus thymidine kinase gene.
Cancer 1995;75(6 Suppl):1467-71.
1995: Toge T; Hirai T; Takiyama W; Takashima N; Kawano K; Tamura Y; Nishimawari K; Iwamori S; Nakanishi K; Kono H
[Clinical effects of FUT-187 in reflux esophagitis after gastrectomy]
Gan to kagaku ryoho. Cancer & chemotherapy 1995;22(4):539-46.
1995: Yamaguchi Y; Miyahara E; Funakoshi M; Takashima I; Kawami H; Sato Y; Toge T
Modulation of CD4 antigen expression on the lymphocyte surface by immunosuppressive acidic protein in cancer patients.
Oncology 1995;52(1):1-6.
1995: Nishiyama M; Takashima I; Tanaka T; Yoshida K; Toge T; Nagata N; Iwamori S; Tamura Y
Carcinoembryonic antigen levels in the peritoneal cavity: useful guide to peritoneal recurrence and prognosis for gastric cancer.
World journal of surgery 1995;19(1):133-7; discussion 137.
1995: Hirai T; Iwata T; Hirabayashi N; Yamashita Y; Yoshimoto A; Noma K; Toge T
Clinical usefulness of an ATP heat sensitivity test using endoscopic biopsy materials from esophageal cancer patients.
Surgery today 1995;25(8):684-9.
1995: Hirai T; Saeki S; Matsuki K; Yamashita Y; Iwata T; Yoshimoto A; Toge T
Preservation of the lower esophageal sphincter during total gastrectomy for gastric cancer to prevent postoperative reflux esophagitis.
Surgery today 1995;25(6):507-14.
1994: Yamashita Y; Hirai T; Saeki S; Yoshimoto A; Noma K; Toge T
[Comparison of duodenogastric reflux (DGR) to esophageal substitute between retro-sternal route and posterior mediastinal route]
[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai 1994;42(10):1897-903.
1994: Yamaguchi Y; Noma K; Miyahara E; Funakoshi M; Takashima I; Kawami H; Sawamura A; Toge T
[Skin reaction to OK-432 and its dosage for locoregional administration]
Gan to kagaku ryoho. Cancer & chemotherapy 1994;21(13):2108-10.
1994: Yamaguchi Y; Takashima I; Funakoshi M; Kawami H; Toge T
Defective natural killer activity in gastric cancer patients: possible involvement of suppressor factor receptor.
In vivo (Athens, Greece) 1994;8(3):279-83.
1994: Kuroi K; Sato Y; Yamaguchi Y; Toge T
Modulation of suppressor cell activities by cyclophosphamide in breast cancer patients.
Journal of clinical laboratory analysis 1994;8(3):123-7.
1994: Mukaida H; Hirabayashi N; Hirai T; Yamashita Y; Iwata T; Saeki S; Toge T
The inhibitory effect caused by suramin on the paracrine growth of human cancer cells and fibroblasts.
Surgery today 1994;24(3):234-40.
1993: Yanagihara K; Ito A; Toge T; Numoto M
Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract.
Cancer research 1993;53(23):5815-21.
1993: Shakil A; Hirabayashi N; Toge T
Circadian variation of 5-fluorouracil and cis-platinum toxicity in mice.
Hiroshima journal of medical sciences 1993;42(4):147-54.
1993: Funakoshi M; Yamaguchi Y; Takashima I; Kawami H; Sawamura A; Toge T
[The analysis of homing receptors on peripheral blood lymphocytes in cancer patients: preliminary report]
Nippon Geka Gakkai zasshi 1993;94(12):1320.
1993: Arihiro K; Inai K; Kurihara K; Takeda S; Khatun N; Kuroi K; Toge T
A role of VLA-6 laminin receptor in invasion of breast carcinoma.
Acta pathologica japonica 1993;43(11):662-9.
1993: Kawami H; Yoshida K; Ohsaki A; Kuroi K; Nishiyama M; Toge T
Stromelysin-3 mRNA expression and malignancy: comparison with clinicopathological features and type IV collagenase mRNA expression in breast tumors.
Anticancer research 1993;13(6A):2319-23.
1993: Aogi K; Sawamura A; Funakoshi M; Toge T
[Intra-arterial infusion chemotherapy of cisplatin (CDDP)-lipiodol suspension using implantable injection port for unresectable liver cancer patients]
Gan to kagaku ryoho. Cancer & chemotherapy 1993;20(11):1485-8.
1993: Arihiro K; Inai K; Kurihara K; Takeda S; Kaneko M; Kuroi K; Toge T
Loss of VLA-2 collagen receptor in breast carcinoma, facilitating invasion and metastasis.
Japanese journal of cancer research : Gann 1993;84(7):726-33.
1993: Arihiro K; Inai K; Kurihara K; Takeda S; Khatun N; Kuroi K; Kawami H; Toge T
Myxoma of the breast: report of a case with unique histological and immunohistochemical appearances.
Acta pathologica japonica 1993;43(6):340-6.
1993: Nishiyama M; Saeki S; Aogi K; Hirabayashi N; Toge T
[Mitomycin C and its bioreduction: relevance of NAD(P)H: quinone oxidoreductase activity to mitomycin C-induced DNA damage and cytotoxicity]
Gan to kagaku ryoho. Cancer & chemotherapy 1993;20(8):1037-41.
1993: Nishiyama M; Saeki S; Aogi K; Hirabayashi N; Toge T
Relevance of DT-diaphorase activity to mitomycin C (MMC) efficacy on human cancer cells: differences in in vitro and in vivo systems.
International journal of cancer. Journal international du cancer 1993;53(6):1013-6.
1993: Kawami H; Yoshida K; Yamaguchi Y; Saeki T; Toge T
The expression and biological activity of IL-2 receptor on a human pancreas cancer cell line.
Biotherapy (Dordrecht, Netherlands) 1993;6(1):33-9.
1993: Kuroi K; Osaki A; Yamada H; Toi M; Toge T; Takimoto Y; Kuramoto A; Arihiro K; Inai K
Primary squamous cell carcinoma of the breast after cured Hodgkin's disease.
Surgery today 1993;23(1):81-4.
1993: Toge T; Yamaguchi Y; Sawamura A
The role of lymphocyte surface binding sites for wheat germ agglutinin in the negative regulation of cancer patients.
Surgery today 1993;23(9):765-70.
1992: Osaki A; Toi M; Yamada H; Kawami H; Kuroi K; Toge T
Prognostic significance of co-expression of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer patients.
American journal of surgery 1992;164(4):323-6.
1992: Toge T; Yamaguchi Y
[Lymphokine-activated killer cell adoptive immunotherapy for cancer treatment and its significance]
Human cell : official journal of Human Cell Research Society 1992;5(3):218-25.
1992: Hirai T; Iwata T; Yamashita Y; Mukaida H; Saeki S; Toge T
Investigation of suitability of devascularized upper half of the whole stomach as replacement for the esophagus.
Hiroshima journal of medical sciences 1992;41(2):25-30.
1992: Nishiyama M; Aogi K; Saeki S; Kim R; Kuroi K; Yamaguchi Y; Toge T
A role for plasma membrane potential in doxorubicin--induced cytotoxicity.
Anticancer research 1992;12(3):849-52.
1992: Kim R; Hirabayashi N; Nishiyama M; Jinushi K; Toge T; Okada K
Experimental studies on biochemical modulation targeting topoisomerase I and II in human tumor xenografts in nude mice.
International journal of cancer. Journal international du cancer 1992;50(5):760-6.
1992: Toge T
[Significance of blood purification in cancer therapy]
Nippon rinsho. Japanese journal of clinical medicine 1992;50 Suppl():357-63.
1992: Kim R; Hirabayashi N; Nishiyama M; Jinushi K; Toge T; Okada K
Factors contributing to adriamycin sensitivity in human xenograft tumors: the relationship between expression of the MDR1, GST-pi and topoisomerase II genes and tumor sensitivity to adriamycin.
Anticancer research 1992;12(1):241-5.
1991: Nishiyama M; Aogi K; Saeki S; Hirabayashi N; Toge T
[Combination of a biscoclaurine alkaloid, cepharanthine, and anticancer agents: effects and mechanism in human gastric and pancreatic carcinoma cell lines]
Gan to kagaku ryoho. Cancer & chemotherapy 1991;18(14):2429-33.
1991: Yamaguchi Y; Takayama T; Kawami H; Sato Y; Baba N; Kuroi K; Toge T
[LAK cell adoptive immunotherapy and its problems]
Nippon Geka Gakkai zasshi 1991;92(9):1234-6.
1991: Kuniyasu H; Yoshida K; Yokozaki H; Yasui W; Ito H; Toge T; Ciardiello F; Persico M G; Saeki T; Salomon D S
Expression of cripto, a novel gene of the epidermal growth factor family, in human gastrointestinal carcinomas.
Japanese journal of cancer research : Gann 1991;82(9):969-73.
1991: Kim R; Hirabayashi N; Nishiyama M; Aogi K; Toge T
Clinical significance of P-glycoprotein expression analyzed by immunohistochemical staining in cancer tissues.
The Japanese journal of surgery 1991;21(5):590-3.
1991: Kim R; Hirabayashi N; Nishiyama M; Yorishima T; Toge T; Okada K
mRNA expression of topoisomerase II in human tumors and normal tissues.
The Japanese journal of surgery 1991;21(5):587-9.
1991: Jinushi K; Sawamura A; Aogi K; Toge T
[Loco-regional cancer therapy for hepatic metastasis]
Gan to kagaku ryoho. Cancer & chemotherapy 1991;18(11):1860-3.
1991: Toge T; Jinushi K; Sawamura A; Matsuki K
[Study on the intra-tumor tissue concentration of zinostatin stimalamer in the liver following intra-arterial injection of zinostatin stimalamer (YM881) suspension]
Gan to kagaku ryoho. Cancer & chemotherapy 1991;18(10):1677-80.
1991: Mukaida H; Toi M; Hirai T; Yamashita Y; Toge T
Clinical significance of the expression of epidermal growth factor and its receptor in esophageal cancer.
Cancer 1991;68(1):142-8.
1991: Hirai T; Kawano K; Hirabayashi N; Nishiyama M; Yamashita Y; Mukaida H; Iwata T; Toge T
A novel in vitro chemosensitivity test using materials collected by endoscopic biopsy.
Anti-cancer drugs 1991;2(3):269-74.
1991: Osaki A; Toi M; Yamada H; Kawami H; Kuroi K; Toge T
[Prognostic significance of expression of c-ERBB-2 oncoprotein in breast cancer patients]
Gan to kagaku ryoho. Cancer & chemotherapy 1991;18(7):1181-5.
1991: Mukaida H; Hirabayashi N; Hirai T; Iwata T; Saeki S; Toge T
Significance of freshly cultured fibroblasts from different tissues in promoting cancer cell growth.
International journal of cancer. Journal international du cancer 1991;48(3):423-7.
1991: Yanagawa E; Toge T; Yamaguchi Y; Kuninobu H; Kuroi K; Kegoya Y; Baba N; Takayama T; Sato Y
Effects of the oral or intratumoral administration of OK432 on the immuno-reactivities of regional lymph nodes in gastric cancer patients.
The Japanese journal of surgery 1991;21(3):297-303.
1991: Jinushi K; Hirabayashi N; Toge T
[Establishment of tumor metastasis model of gastric cancer in nude mouse: preliminary report]
Nippon Geka Gakkai zasshi 1991;92(1):105.
1991: Kim R; Hirabayashi N; Nishiyama M; Saeki S; Toge T; Okada K
Expression of MDR1, GST-pi and topoisomerase II as an indicator of clinical response to adriamycin.
Anticancer research 1991;11(1):429-31.
1991: Yoshinaka K; Yagi M; Ohtagaki S; Toi M; Toge T
[5'-deoxy-5-fluorouridine (5'-DFUR), mitomycin C (MMC), etoposide and medroxy progesterone acetate (MPA) in a previously treated patient with advanced breast cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 1991;18(1):115-8.
1991: Toi M; Osaki A; Yamada H; Toge T
Epidermal growth factor receptor expression as a prognostic indicator in breast cancer.
European journal of cancer (Oxford, England : 1990) 1991;27(8):977-80.
1991: Baba N; Kawami H; Sato Y; Takayama T; Toge T
The augmentative effect of a protein-bound polysaccharide (PSK) on tumoricidal activity of the soluble factor produced by a streptococcal preparation (OK-432)-activated macrophages.
Biotherapy (Dordrecht, Netherlands) 1991;3(4):359-64.
1990: Jinushi K; Hirabayashi N; Kirihara Y; Takagami S; Ryuji K; Yorishima T; Nishiyama M; Noso Y; Toge T
[Clinical studies of in vitro chemosensitivity test evaluated by ATP assay of gastrointestinal cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 1990;17(11):2235-9.
1990: Yamashita Y; Hirai T; Mukaida H; Iwata T; Toge T; Hoon H J
A new experimental trial using repeated heating every 24 hours for local hyperthermic therapy with bleomycin in vivo.
The Japanese journal of surgery 1990;20(6):671-6.
1990: Miyahara E; Toi M; Wada T; Yamada H; Osaki A; Yanagawa E; Toge T
[The expression of NCC-ST-439, a tumor marker, in human breast cancer patients]
Gan no rinsho. Japan journal of cancer clinics 1990;36(11):2023-6.
1990: Yoshida K; Tsujino T; Yasui W; Kameda T; Sano T; Nakayama H; Toge T; Tahara E
Induction of growth factor-receptor and metalloproteinase genes by epidermal growth factor and/or transforming growth factor-alpha in human gastric carcinoma cell line MKN-28.
Japanese journal of cancer research : Gann 1990;81(8):793-8.
1990: Kuroi K; Sato Y; Takayama T; Baba N; Yamaguchi Y; Toge T
Lymphocyte subpopulations in peripheral blood and the spleen from gastric cancer patients.
Hiroshima journal of medical sciences 1990;39(2):23-7.
1990: Toi M; Nakamura T; Mukaida H; Wada T; Osaki A; Yamada H; Toge T; Niimoto M; Hattori T
Relationship between epidermal growth factor receptor status and various prognostic factors in human breast cancer.
Cancer 1990;65(9):1980-4.
1990: Enoki Y; Niwa O; Yokoro K; Toge T
Analysis of clonal evolution in a tumor consisting of pSV2neo-transfected mouse fibrosarcoma clones.
Japanese journal of cancer research : Gann 1990;81(2):141-7.
1990: Yamaguchi Y; Toge T; Baba N; Kuninobu H; Kegoya Y; Takayama T; Hattori T
The analysis of lymphocyte surface receptors recognized by wheat germ agglutinin for negative regulation of immune responses in cancer patients.
The Japanese journal of surgery 1990;20(1):51-5.
1990: Toi M; Mukaida H; Wada T; Hirabayashi N; Toge T; Hori T; Umezawa K
Antineoplastic effect of erbstatin on human mammary and esophageal tumors in athymic nude mice.
European journal of cancer (Oxford, England : 1990) 1990;26(6):722-4.
1990: Toge T; Kuroi K; Baba N; Kegoya Y; Takayama T; Yanagawa E
Interference of the induction of suppressor cells by a streptococcal preparation, OK-432 through the blocking of suppressor inducer T-cells.
International journal of immunopharmacology 1990;12(1):107-12.
1989: Toi M; Nakamura T; Wada T; Yamamoto A; Toge T; Niimoto M; Hattori T
The acceptable delay between biopsy and radical mastectomy in breast cancer patients.
The Japanese journal of surgery 1989;19(6):679-83.
1989: Nishiyama M; Kim R; Jinushi K; Takagami S; Kirihara Y; Toge T
Antitumor effect of KW2149, a new mitomycin derivative, administered by different modalities.
In vivo (Athens, Greece) 1989;3(6):375-9.
1989: Toi M; Nakamura T; Wada T; Yamamoto A; Toge T; Niimoto M; Hattori T
The discrepancy between immunocytochemical and biochemical assay of estrogen receptor in breast cancer patients treated by endocrine therapy.
The Japanese journal of surgery 1989;19(6):768-72.
1989: Mukaida H; Hirai T; Toi M; Nakamura T; Yamashita Y; Kawano K; Toge T; Niimoto M; Hattori T
[Expression of the epidermal growth factor receptor in esophageal cancer]
Gan no rinsho. Japan journal of cancer clinics 1989;35(12):1399-406.
1989: Toge T; Takayama T; Kegoya Y; Kuninobu H; Yamaguchi Y; Hattori T
[Clinical efficacy of LAK cell adoptive immunotherapy in advanced cancer patients]
Nippon Geka Gakkai zasshi 1989;90(9):1455-8.
1989: Kuninobu H; Toge T; Takayama T; Baba N; Kegoya Y; Yanagawa E
[Clinical efficacy of intratumoral administration of BRM in advanced cancer and their mechanism of actions]
Gan to kagaku ryoho. Cancer & chemotherapy 1989;16(8 Pt 2):2769-73.
1989: Yamashita Y; Hirai T; Mukaida H; Kawano K; Toge T; Niimoto M; Hattori T; Kunita T
Primary malignant melanoma of the esophagus--a case report.
The Japanese journal of surgery 1989;19(4):498-501.
1989: Nishiyama M; Hirono M; Takagami S; Kim R; Saeki T; Kirihara Y; Jinushi K; Yanagawa E; Toge T; Niimoto M
The histological assessment and evaluation of a 4 day subrenal capsule assay by the percentage inhibition of DNA/protein.
The Japanese journal of surgery 1989;19(4):403-9.
1989: Yamashita Y; Hirai T; Mukaida H; Kawano K; Toge T; Niimoto M; Hattori T
[Submucosal injection of lipiodol-bleomycin in esophageal cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 1989;16(5):2075-9.
1989: Niimoto M; Jinushi K; Kirihara Y; Yamamoto T; Kuninobu H; Saeki T; Yanagawa E; Toge T; Hattori T
[Evaluation and problems of second-look operations in resectable gastric cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 1989;16(4 Pt 2-2):1295-8.
1989: Toge T; Kegoya Y; Yamaguchi Y; Baba N; Kuninobu H; Takayama T; Yanagawa E; Hattori T
[Surgical stress and immunosuppression in cancer patients]
Gan to kagaku ryoho. Cancer & chemotherapy 1989;16(4 Pt 2-1):1115-21.
1989: Yamashita Y; Hirai T; Mukaida H; Kawano K; Toge T; Niimoto M; Hattori T
Detection of androgen receptors in human esophageal cancer.
The Japanese journal of surgery 1989;19(2):195-202.
1989: Hirai T; Yamashita Y; Mukaida H; Kawano K; Toge T; Niimoto M; Hattori T
Bypass operation for advanced esophageal cancer--an analysis of 93 cases.
The Japanese journal of surgery 1989;19(2):182-8.
1989: Toi M; Hamada Y; Nakamura T; Mukaida H; Suehiro S; Wada T; Toge T; Niimoto M; Hattori T
Immunocytochemical and biochemical analysis of epidermal growth factor receptor expression in human breast cancer tissues: relationship to estrogen receptor and lymphatic invasion.
International journal of cancer. Journal international du cancer 1989;43(2):220-5.
1989: Toge T; Yamaguchi Y; Kegoya Y; Baba N; Yanagawa E; Hattori T
Blocking of lymphocyte surface binding sites for the soluble suppressor factor by protein-bound polysaccharide, PSK.
International journal of immunopharmacology 1989;11(1):9-12.
1988: Toge T; Kuroi K; Kuninobu H; Yamaguchi Y; Kegoya Y; Baba N; Hattori T
Role of the spleen in immunosuppression of gastric cancer: predominance of suppressor precursor and suppressor inducer T cells in the recirculating spleen cells.
Clinical and experimental immunology 1988;74(3):409-12.
1988: Toge T; Kuninobu H; Yamaguchi Y; Baba N; Kegoya Y; Hattori T
The clinical efficacy of intratumoral OK-432 administration in advanced cancer patients.
The Japanese journal of surgery 1988;18(6):668-74.
1988: Nishiyama M; Kim R; Saeki T; Takagami S; Kirihara Y; Jinushi K; Toge T; Niimoto M; Hattori T
[Anticancer activities of a new mitomycin derivative KW 2149, against human tumors xenografted into nude mice]
Gan to kagaku ryoho. Cancer & chemotherapy 1988;15(11):3133-7.
1988: Yanagawa E; Toge T; Sawamura A; Kegoya Y; Baba N; Hattori T
The regulation of natural killer cell activity by splenic nonspecific suppressor cells and its modification in cancer patients.
The Japanese journal of surgery 1988;18(6):660-7.
1988: Saeki T; Jinushi K; Kodama H; Yoshinaka K; Toge T; Niimoto M; Hattori T
[Fundamental and clinical studies of intra-arterial chemotherapy combined with degradable starch microspheres (DSM)]
Gan to kagaku ryoho. Cancer & chemotherapy 1988;15(8 Pt 2):2633-9.
1988: Nishiyama M; Takagami S; Kirihara Y; Saeki T; Niimi K; Kim R; Jinushi K; Toge T; Niimoto M; Hattori T
[Combined effects of interferon alpha-A/D with fluoropyrimidine derivatives in the subrenal capsule assay]
Gan to kagaku ryoho. Cancer & chemotherapy 1988;15(8):2285-90.
1988: Saeki T; Kuninobu H; Kodama H; Nishiyama M; Yoshinaka K; Toge T; Niimoto M; Hattori T
[Multidisciplinary treatment of unresectable liver cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 1988;15(8 Pt 2):2583-9.
1988: Yoshinaka K; Tanaka T; Takagami S; Saeki T; Nishiyama M; Toge T; Niimoto M; Hattori T
[Prospective randomized controlled study of bestatin in gastric cancer surgery]
Gan to kagaku ryoho. Cancer & chemotherapy 1988;15(3):493-8.
1988: Toi M; Hamada Y; Seto Y; Tanimoto M; Nakamura T; Toge T; Niimoto M; Hattori T
Immunocytochemical study on the variation in estrogen receptors of primary and nodal metastases of breast cancer.
The Japanese journal of surgery 1988;18(2):228-31.
1987: Noso Y; Niimi K; Nishiyama M; Hirabayashi N; Toge T; Niimoto M; Hattori T
Clinical studies on a new screening assay for anticancer agents using nude mice and isotopic evaluation.
Cancer research 1987;47(23):6418-22.
1987: Yamashita Y; Hirai T; Miyoshi Y; Ohtagaki S; Mukaida H; Toge T; Niimoto M; Hattori T
[Dependency on sex hormone in human esophageal cancer--measurement of the androgen receptor in resected specimens]
Gan no rinsho. Japan journal of cancer clinics 1987;33(11):1303-8.
1987: Hirabayashi N; Nishiyama M; Niimi K; Yamaguchi M; Toge T; Niimoto M; Hattori T
Effect of oxygen tension on the antitumor activity of mitomycin C assayed by human tumor clonogenic assay.
The Japanese journal of surgery 1987;17(5):402-6.
1987: Hirono M; Mandai K; Toge T; Niimoto M; Hattori T; Fujimoto K; Haruma K
Intestinal metaplasia of the stomach confined to the fundic gland area. Report of two cases.
The Japanese journal of surgery 1987;17(4):276-80.
1987: Nosoh Y; Toge T; Niimi K; Nishiyama M; Hirabayashi N; Nakanishi K; Niimoto M; Hattori T
Experimental studies on the combined effects of alpha and gamma interferons against human tumor xenografts transplanted into nude mice.
The Japanese journal of surgery 1987;17(3):168-73.
1987: Niimi K; Nishiyama M; Hirabayashi N; Yamaguchi M; Nosoh Y; Wang D C; Toge T; Niimoto M; Hattori T
[In vivo chemosensitivity test for UFT and FT-207. II. Chemosensitivity test on human tumor xenografts transplanted in nude mice]
Gan to kagaku ryoho. Cancer & chemotherapy 1987;14(5 Pt 1):1281-5.
1987: Nosoh Y; Nishiyama M; Niimi K; Hirabayashi N; Toge T; Niimoto M; Hattori T
Antitumor activities of KW-2152, a new isoquinon agent, against human tumor xenografts transplanted into nude mice.
The Japanese journal of surgery 1987;17(2):146-9.
1987: Hirabayashi N; Noso Y; Niimi K; Nishiyama M; Yamaguchi M; Toge T; Niimoto M; Hattori T
Comparative studies on in vitro human tumor clonogenic assay (HTCA) and in vivo nude mouse-isotope assay (NM-IA).
The Japanese journal of surgery 1987;17(2):104-9.
1987: Toge T; Seto Y; Kuroi K; Yamada H; Aratani K; Fujita T; Yanagawa E; Hattori T
Relationship of the distribution of Leu-2+ cells with suppressor cell activities in the spleen and lymph-nodes from gastric cancer.
The Japanese journal of surgery 1987;17(2):72-7.
1987: Kuroi K; Toge T; Yamaguti Y; Kameda A; Seto Y; Hattori T
[Analysis of lymphocyte subpopulations of the spleen in patients with gastric cancer and liver cirrhosis]
Nippon Geka Gakkai zasshi 1987;88(1):127.
1987: Toge T; Yamada H; Aratani K; Yamaguchi M; Fujita T; Yanagawa E; Hattori T
Reduction of suppressor cell activities of human peripheral blood lymphocytes by a streptococcal preparation, OK-432.
International journal of immunopharmacology 1987;9(8):875-9.
1986: Toge T; Hirai T; Miyoshi Y; Yoshihara T; Ohtagaki S; Yamashita Y; Niimoto M; Hattori T
[Late results of operative removal of esophageal cancer with special reference to blunt dissection]
Gan no rinsho. Japan journal of cancer clinics 1986;32(15):1909-17.
1986: Hirono M; Niimoto M; Toge T; Hattori T; Oride M; Nakajima T; Hirata K; Kimura T; Nakazato H; Iwanaga T
A cohort study on second malignancies in gastrectomized patients with gastric cancer. II. Second malignancies in the gastric remnant.
The Japanese journal of surgery 1986;16(5):344-50.
1986: Hirono M; Niimoto M; Toge T; Hattori T; Oride M; Nakajima T; Hirata K; Kimura T; Nakazato H; Iwanaga T
A cohort study on second malignancies in gastrectomized patients with gastric cancer. I. Second malignancies other than cancer of the gastric remnant.
The Japanese journal of surgery 1986;16(5):336-43.
1986: Toge T; Kameda A; Yamada H; Seto Y; Aratani K; Fujita T; Hattori T
Role of the spleen on immunosuppression in esophageal and gastric cancer.
The Japanese journal of surgery 1986;16(5):330-5.
1986: Hisamatsu K; Toge T; Yanagawa E; Hamada Y; Seto Y; Yamada H; Toi M; Hattori T
[Immune reactivities of lymphocytes from peripheral blood, regional lymph nodes and tumor-infiltrating lymphocytes in breast cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 1986;13(8):2555-61.
1986: Nishiyama M; Noso Y; Hirabayashi N; Yamaguchi M; Toge T; Niimoto M; Hattori T
Prediction of individual tumor chemosensitivity in subrenal capsule assay.
The Japanese journal of surgery 1986;16(4):257-61.
1986: Toge T; Tomota S; Aratani K; Kameda A; Yamada H; Yanagawa E; Hattori T
[Development of cancer immunotherapy by a combination of biological response modifiers on the basis of their mechanism of action]
Gan to kagaku ryoho. Cancer & chemotherapy 1986;13(4 Pt 2):1258-63.
1986: Hirabayashi N; Nosoh Y; Toge T; Yoshinaka K; Yamaguchi M; Nishiyama M; Niimoto M; Hattori T
[In vitro phase II-III study by clonogenic assay: the combined effects of mitomycin C with alpha-interferon]
Gan to kagaku ryoho. Cancer & chemotherapy 1986;13(3 Pt 1):531-5.
1986: Nishiyama M; Noso Y; Yamaguchi M; Hirabayashi N; Toge T; Niimoto M; Hattori T
[Sensitivity test of anticancer agents by subrenal capsule assay (SRC assay). II--Determination of tumor sensitivity by percentage inhibition of DNA protein]
Gan to kagaku ryoho. Cancer & chemotherapy 1986;13(2):275-9.
1985: Kameda A; Toge T; Yamada H; Aratani K; Kuroi K; Niimoto M; Hattori T
[Clinical studies on plasma exchange in advanced cancer patients with special reference to the postcentrifugal filter]
Gan no rinsho. Japan journal of cancer clinics 1985;31(13):1661-4.
1985: Toge T; Kameda A; Kuroi K; Seto Y; Yamada H; Hattori T
[The role of the spleen in immunosuppression and the effects of splenectomy on prognosis in gastric cancer patients]
Nippon Geka Gakkai zasshi 1985;86(9):1120-3.
1985: Hirabayashi N; Yoshinaka K; Nosoh Y; Toge T; Niimoto M; Hattori T; Ohkita T
In vitro chemosensitivity tests on human tumor xenografts by clonogenic assay: the combined use of mitomycin C with alpha-interferon or gamma-interferon.
The Japanese journal of surgery 1985;15(4):279-84.
1985: Toge T; Yamada H; Aratani K; Kameda A; Kuroi K; Hisamatsu K; Hattori T
Effects of intraperitoneal administration of OK-432 for patients with advanced cancer.
The Japanese journal of surgery 1985;15(4):260-5.
1985: Hirabayshi N; Nishiyama M; Yamaguchi M; Yoshinaka K; Nosoh Y; Toge T; Niimoto M; Hattori T; Ohkita T
[Assessment of the combined effects of mitomycin C with alpha-interferon or gamma-interferon by the clonogenic assay technique]
Gan to kagaku ryoho. Cancer & chemotherapy 1985;12(5):1056-62.
1984: Nosoh Y; Yoshinaka K; Yamaguchi M; Tani T; Toge T; Niimoto M; Hattori T
[Increased cytotoxic effects of various anticancer drugs by alpha-interferon (HLBI) on human tumor xenografts in nude mice]
Gan to kagaku ryoho. Cancer & chemotherapy 1984;11(8):1623-8.
1984: Hirono M; Yoshinaka K; Matsuki K; Noso Y; Oride M; Toge T; Niimoto M; Hattori T
[Surgical treatment of Borrmann type 4 (diffuse) gastric cancer]
Gan no rinsho. Japan journal of cancer clinics 1984;30(6 Suppl):717-23.
1983: Hattori T; Niimoto M; Toge T; Oride M; Nakao A; Yoshinaka K
Effects of Levamisole in adjuvant immunochemotherapy for gastric cancer; a prospective randomized controlled study.
The Japanese journal of surgery 1983;13(6):480-5.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Tetsuya Toge

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Living Beings

Anatomy

Physiology

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Tetsuya Toge (preview)

All Publications